These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11298837)

  • 1. Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.
    O'Hara AM; Moran AP; Würzner R; Orren A
    Immunology; 2001 Mar; 102(3):365-72. PubMed ID: 11298837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
    J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation.
    Bloch EF; Knight EM; Carmon T; McDonald-Pinkett S; Carter J; Boomer A; Ogunfusika M; Petersen M; Famakin B; Aniagolu J; Walker J; Gant R; Walters CS; Gaither TA
    Immunol Invest; 1997 Jun; 26(4):409-19. PubMed ID: 9246562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.
    Joiner KA; Schmetz MA; Sanders ME; Murray TG; Hammer CH; Dourmashkin R; Frank MM
    Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4808-12. PubMed ID: 3895225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
    Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
    Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores.
    Doorduijn DJ; Heesterbeek DAC; Ruyken M; de Haas CJC; Stapels DAC; Aerts PC; Rooijakkers SHM; Bardoel BW
    PLoS Pathog; 2021 Nov; 17(11):e1010051. PubMed ID: 34752492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
    Weiss J; Beckerdite-Quagliata S; Elsbach P
    J Clin Invest; 1980 Mar; 65(3):619-28. PubMed ID: 6986410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on serum resistance in Escherichia coli.
    Kubens BS; Opferkuch W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):52-65. PubMed ID: 3146846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    Joiner KA; Hammer CH; Brown EJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
    Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
    J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.
    Dankert JR; Esser AF
    Biochem J; 1987 Jun; 244(2):393-9. PubMed ID: 3311029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
    Joiner KA; Goldman R; Schmetz M; Berger M; Hammer CH; Frank MM; Leive L
    J Immunol; 1984 Jan; 132(1):369-75. PubMed ID: 6197449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death.
    Harriman GR; Podack ER; Braude AI; Corbeil LC; Esser AF; Curd JG
    J Exp Med; 1982 Oct; 156(4):1235-49. PubMed ID: 6818318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of Escherichia coli with normal human serum: factors affecting the capacity of serum to mediate lipopolysaccharide release.
    Tesh VL; Morrison DC
    Microb Pathog; 1988 Mar; 4(3):175-87. PubMed ID: 3143040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of C9-deficient human serum.
    Pramoonjago P; Kinoshita T; Hong KS; Takata-Kozono Y; Kozono H; Inagi R; Inoue K
    J Immunol; 1992 Feb; 148(3):837-43. PubMed ID: 1730876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of transmural complement pores in serum-sensitive Escherichia coli.
    Bhakdi S; Kuller G; Muhly M; Fromm S; Seibert G; Parrisius J
    Infect Immun; 1987 Jan; 55(1):206-10. PubMed ID: 3539803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated killing of Escherichia coli: dissipation of membrane potential by a C9-derived peptide.
    Dankert JR; Esser AF
    Biochemistry; 1986 Mar; 25(5):1094-100. PubMed ID: 3516214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.